Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Non-Randomized Feasibility Study of the Hemolung Respiratory Assist System in Patients With Acute Hypercapnic Respiratory Failure

NCT01021605 is registered in ClinicalTrials.gov with Alung Technologies as lead sponsor.

NCT NCT01021605
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01021605 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Non-Randomized Feasibility Study of the Hemolung Respiratory Assist System in Patients With Acute Hypercapnic Respiratory Failure
Lead sponsor
Alung Technologies
Phase
Not applicable
Overall status
Completed
Start date
December 31, 2009
Completion date
May 31, 2012
Enrollment
21 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

hypercapnic respiratory failure, copd, ards